Cargando…
Pathology is a critical aspect of preclinical aging studies
Experimental design for mouse aging studies has historically involved lifespan, but it is now clear that survival data without pathology data limit the information that can be obtained on aging animals. This limitation becomes more serious when interventions of any sort are implemented. Pathology gi...
Autores principales: | Ladiges, Warren, Ikeno, Yuji, Liggitt, Denny, Treuting, Piper M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749367/ https://www.ncbi.nlm.nih.gov/pubmed/23970952 http://dx.doi.org/10.3402/pba.v3i0.22451 |
Ejemplares similares
-
Testing drug combinations to slow aging
por: Ladiges, Warren, et al.
Publicado: (2017) -
Pathology assessment is necessary to validate translational endpoints in preclinical aging studies
por: Ladiges, Warren
Publicado: (2016) -
The emerging role of geropathology in preclinical aging studies
por: Ladiges, Warren
Publicado: (2017) -
Neuropathological assessment and validation of mouse models for Alzheimer's disease: applying NIA-AA guidelines
por: Keene, C. Dirk, et al.
Publicado: (2016) -
Practical pathology of aging mice
por: Pettan-Brewer, Christina, et al.
Publicado: (2011)